The pharmacological treatment of opioid addiction—a clinical perspective Philipp LobmaierMichael GossopJorgen Bramness Review Article 19 February 2010 Pages: 537 - 545
Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review Sabrina CrépinMarie-Laure LarocheLouis Merle Review Article 01 May 2010 Pages: 547 - 554
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD) Robert M. WardBrinda TammaraGail M. Comer Clinical Trial 20 March 2010 Pages: 555 - 561
Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers Yongqing WangHongwen ZhangRuihua Shi Pharmacodynamics 23 April 2010 Pages: 563 - 569
In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population Natasa DjordjevicJuan Antonio CarrilloEleni Aklillu Pharmacogenetics 13 February 2010 Pages: 571 - 578
Explaining variability in ciclosporin exposure in adult kidney transplant recipients Rogier R. PressBart A. PloegerHenk-Jan Guchelaar Pharmacogenetics Open access 31 March 2010 Pages: 579 - 590
VKORC1 −1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement Helene PuehringerRalph M. LorethChristian Oberkanins Pharmacogenetics 08 April 2010 Pages: 591 - 598
Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies Juan José TorradoMaría BlancoAlfredo García-Arieta Pharmacokinetics and Disposition 27 February 2010 Pages: 599 - 604
Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence? Eloni T. RottaSérgio L. AmantéaAdriana Becker Pharmacokinetics and Disposition 27 February 2010 Pages: 605 - 610
Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism Jan Gerard MaringFloris M. WachtersHarry J. M. Groen Pharmacokinetics and Disposition Open access 06 March 2010 Pages: 611 - 617
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study Bjorn GudbjornssonSigurdur B. ThorsteinssonGudmundur Thorgeirsson Pharmacoepidemiology and Prescription 16 February 2010 Pages: 619 - 625
A pilot study to evaluate a community pharmacy–based monitoring system to identify adverse drug reactions associated with paediatric medicines use Mansour TobaiqyDerek StewartJames McLay Pharmacoepidemiology and Prescription 02 March 2010 Pages: 627 - 632
Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol Belen Ruiz-AntoránAntònia Agustí EscasanyEugenio Gómez Ontañón Pharmacoepidemiology and Prescription 05 March 2010 Pages: 633 - 641
Warfarin-flucloxacillin interaction presenting as cardioembolic ischemic stroke Áine MerwickNiamh HannonKillian O’Rourke Letter to the Editors 05 March 2010 Pages: 643 - 644
Very late relapse of dapsone-induced methaemoglobinemia Guillaume MoulisHaleh BagheriJean-Louis Montastruc Letter to the Editors 13 March 2010 Pages: 645 - 646
